SE7605620L - Farmakologiskt aktiva foreningar - Google Patents

Farmakologiskt aktiva foreningar

Info

Publication number
SE7605620L
SE7605620L SE7605620A SE7605620A SE7605620L SE 7605620 L SE7605620 L SE 7605620L SE 7605620 A SE7605620 A SE 7605620A SE 7605620 A SE7605620 A SE 7605620A SE 7605620 L SE7605620 L SE 7605620L
Authority
SE
Sweden
Prior art keywords
pharmacologically active
active associations
associations
pharmacologically
active
Prior art date
Application number
SE7605620A
Other languages
English (en)
Other versions
SE419544B (sv
Inventor
G J Durant
C R Ganellin
R C Young
G R Owen
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB21817/75A external-priority patent/GB1553070A/en
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of SE7605620L publication Critical patent/SE7605620L/sv
Publication of SE419544B publication Critical patent/SE419544B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7605620A 1975-05-21 1976-05-18 Forfarande for framstellning av foreningar, som er antagonister mot vissa verkningar av histamin SE419544B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB21817/75A GB1553070A (en) 1975-05-21 1975-05-21 Thiourea guanidine and 1-nitro-2,2-diaminoethylene derivatives
GB4778275 1975-11-20

Publications (2)

Publication Number Publication Date
SE7605620L true SE7605620L (sv) 1976-11-22
SE419544B SE419544B (sv) 1981-08-10

Family

ID=26255540

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7605620A SE419544B (sv) 1975-05-21 1976-05-18 Forfarande for framstellning av foreningar, som er antagonister mot vissa verkningar av histamin

Country Status (13)

Country Link
US (6) US4098898A (sv)
JP (1) JPS51141865A (sv)
AT (1) AT356131B (sv)
AU (1) AU503525B2 (sv)
CA (1) CA1076581A (sv)
CH (2) CH626883A5 (sv)
DE (1) DE2621834A1 (sv)
DK (1) DK145541C (sv)
FR (1) FR2311536A1 (sv)
IE (1) IE44062B1 (sv)
IL (1) IL49528A (sv)
NL (1) NL7605405A (sv)
SE (1) SE419544B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170652A (en) * 1974-03-12 1979-10-09 Smith Kline & French Laboratories Limited Heterocyclic-methylthioalkyl-guanidines
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
IL57415A (en) * 1978-05-30 1984-08-31 Smith Kline French Lab Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
US4200760A (en) * 1978-09-26 1980-04-29 Bristol-Myers Company Imidazolylalkylthioalkylamino-ethylene derivatives
EP0010893B1 (en) * 1978-10-16 1984-02-08 Imperial Chemical Industries Plc Antisecretory branched-chain heterocyclic guanidine derivatives, processes for their manufacture, intermediates, and pharmaceutical compositions containing said derivatives
US4282363A (en) * 1978-11-24 1981-08-04 Bristol-Myers Company 1-Nitro-2-(2-alkynylamino)-2-[(2-pyridylmethylthio)-ethylamino]ethylene derivatives
JPS568357A (en) * 1979-02-16 1981-01-28 Eisai Co Ltd Cyanoguanidine derivative and its production
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
US4315024A (en) * 1980-08-08 1982-02-09 Cooper Laboratories, Inc. Compositions and method for treating red eye
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4443456A (en) * 1981-05-12 1984-04-17 William H. Rorer, Inc. Pyridyl alkylene amidinoureas
US4810717A (en) * 1981-11-12 1989-03-07 E. I. Du Pont De Nemours And Company 2-hydroxypropylamine aryl ester derivatives
DE3232462A1 (de) * 1982-09-01 1984-03-01 Bayer Ag, 5090 Leverkusen 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4795719A (en) * 1984-05-15 1989-01-03 Waferscale Integration, Inc. Self-aligned split gate eprom process
EP0199845B1 (de) * 1985-04-02 1990-08-01 HEUMANN PHARMA GMBH & CO Imidazolylalkylguanidinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4617311A (en) * 1985-05-17 1986-10-14 Eli Lilly And Company Antiasthmatic method
NL8601585A (nl) * 1986-06-19 1988-01-18 Vereniging Voor Christelijk Wetenschappelijk Onderwijs N-(2-gesubstitueerde alkyl)-n-imidazol-4-yl alkyl guanidine.
DE3631334A1 (de) * 1986-09-15 1988-03-17 Heumann Pharma Gmbh & Co Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4996221A (en) * 1987-01-13 1991-02-26 The Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives as immune modulators
US5229386A (en) * 1989-01-05 1993-07-20 Fujisawa Pharmaceutical Co., Ltd. Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
US5145860A (en) * 1989-01-05 1992-09-08 Fujisawa Pharmaceutical Co., Ltd. Thiazole compounds and pharmaceutical composition comprising the same
NL9100365A (nl) * 1991-02-27 1992-09-16 Seed Capital Investments Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
AU662135B2 (en) * 1991-02-27 1995-08-24 Seed Capital Investments (Sci) B.V. Imidazole-derivatives having agonistic or antagonistic activity on the histamine H3-receptor
WO1993014753A1 (en) * 1992-01-27 1993-08-05 The Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives and methods for their use
US5808090A (en) * 1996-02-22 1998-09-15 Endo Pharmaceuticals Inc. Process for preventing precipitation in cimetidine injection solutions
CA2342607A1 (en) * 1998-09-22 2000-03-30 Ishihara Sangyo Kaisha Ltd. Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
GB0404434D0 (en) * 2004-02-27 2004-03-31 Novartis Ag Organic compounds
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868457A (en) * 1969-10-29 1975-02-25 Smith Kline French Lab Method of inhibiting histamine activity with guanidine compounds
GB1305549A (sv) * 1969-10-29 1973-02-07
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
US3808336A (en) * 1970-06-25 1974-04-30 Smithkline Corp Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3950353A (en) * 1971-03-09 1976-04-13 Smith Kline & French Laboratories Limited Pharmacologically active thiourea and urea compounds
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3905984A (en) * 1971-03-09 1975-09-16 Smith Kline French Lab Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
US4000302A (en) * 1972-04-20 1976-12-28 Smith Kline & French Laboratories Limited Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors
US4000296A (en) * 1972-09-05 1976-12-28 Smith Kline & French Laboratories Limited Imidazole alkylguanidine compounds
US3979398A (en) * 1973-02-08 1976-09-07 Smith Kline & French Laboratories Limited Sulphoxides
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4124717A (en) * 1973-05-17 1978-11-07 Smith Kline & French Laboratories Limited Thiazolyl alkylaminoethylene compounds
US4046907A (en) * 1973-05-17 1977-09-06 Smith Kline & French Laboratories Limited Imidazole alkylaminoethylene compounds
US4152443A (en) * 1973-07-13 1979-05-01 Smith Kline & French Laboratories Limited Imidazolyl thioureas, ureas and guanidines
GB1431589A (en) * 1973-07-13 1976-04-07 Smith Kline French Lab Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups
GB1493931A (en) * 1974-02-07 1977-11-30 Smith Kline French Lab Guanidines isothioureas and thioureas
US4109003A (en) * 1974-03-12 1978-08-22 Smith Kline & French Laboratories Limited Pharmacologically active compounds
US4013769A (en) * 1974-05-09 1977-03-22 Smith Kline & French Laboratories Limited Pyridyl-alkylaminoethylene compounds
GB1497260A (en) * 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives
US4093621A (en) * 1974-09-02 1978-06-06 Smith Kline & French Laboratories Limited Process for preparing heterocyclicalkylthioalkyl-N-cyanoguanidines and thioureas
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
US4154838A (en) * 1975-07-31 1979-05-15 Smith Kline & French Laboratories Limited Alkoxy pyridine
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
NZ186965A (en) * 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
AU1419576A (en) 1977-11-24
US4333946A (en) 1982-06-08
FR2311536B1 (sv) 1979-03-23
US4247558A (en) 1981-01-27
CH624941A5 (sv) 1981-08-31
AU503525B2 (en) 1979-09-06
AT356131B (de) 1980-04-10
US4440775A (en) 1984-04-03
US4347250A (en) 1982-08-31
ATA361576A (de) 1979-09-15
IE44062B1 (en) 1981-08-12
CA1076581A (en) 1980-04-29
US4098898A (en) 1978-07-04
DK145541B (da) 1982-12-06
CH626883A5 (sv) 1981-12-15
SE419544B (sv) 1981-08-10
DK206576A (da) 1976-11-22
FR2311536A1 (fr) 1976-12-17
IL49528A (en) 1980-11-30
NL7605405A (nl) 1976-11-23
JPS51141865A (en) 1976-12-07
IE44062L (en) 1976-11-21
DK145541C (da) 1983-05-16
US4276301A (en) 1981-06-30
IL49528A0 (en) 1976-07-30
DE2621834A1 (de) 1976-12-02

Similar Documents

Publication Publication Date Title
SE7605620L (sv) Farmakologiskt aktiva foreningar
SE437827B (sv) Herbicidiskt aktiva foreningar
SE7507364L (sv) Farmakolgogiskt aktiva foreningar.
SE7710762L (sv) Farmakologiskt aktiva foreningar
IT1070839B (it) Composto farmacologicamente attivi
PT65949A (pt) Pharmacologically active compounds
AR208430A1 (es) Electrodo
DK454176A (da) Galeniske preparater
SE7605825L (sv) Polycykliska foreningar
SE7506947L (sv) Farmakologiskt aktiva foreningar
NL7600906A (nl) Farmacologisch actieve verbindingen.
SE7510988L (sv) Nya farmaceutiskt aktiva foreningar
SE7702771L (sv) Farmakologiskt aktiva foreningar
SE7613407L (sv) Konstruktionsforband
SE7608478L (sv) Farmaceutica
DK559081A (da) Rodenticidt aktive diphenylaminforbindelser
SE7608476L (sv) Farmakologiska foreningar
SE7610842L (sv) Farmakologiskt aktiva foreningar
NL7613093A (nl) Farmacologisch actieve verbindingen.
BE843053A (nl) Stuuropstelling
SE7605158L (sv) Nya organiska foreningar
SE7705857L (sv) Farmaceutiskt aktiva foreningar
SE7506348L (sv) Hjertaktiva foreningar
AT366447B (de) Rueckstau-doppelverschluss
SE7605818L (sv) Nya diureidforeningar